This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review.
Cardiovascular diabetology, 20(1), 21
Citation
Yang, Chen-Yi; Chen, Ying-Ren; Ou, Huang-Tz; Kuo, Shihchen. (2021). Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review.. Cardiovascular diabetology, 20(1), 21. https://doi.org/10.1186/s12933-020-01211-4